[On the incidence of neutralizing antibodies to Coxsackie viruses in the population (author's transl)].
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D000013:Congenital Abnormalities / Q000209:etiology; D003384:Coxsackievirus Infections / Q000150:complications / Q000453:epidemiology / Q000276:immunology; D004770:Enterovirus / Q000276:immunology*; D005260:Female; D005315:Fetal Diseases / Q000209:etiology; D005860:Germany, West; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008431:Maternal-Fetal Exchange; D008875:Middle Aged; D009500:Neutralization Tests; D011247:Pregnancy; D012737:Sex Factors
D000914:Antibodies, Viral
Vorkommen neutralisierender Antikörper gegen Coxsackieviren in der Bevölkerung